Clinical characteristics of study population (n=351)
| Mean±SD or n (%) | P value | |||
| All patients (n=351) | Patients with ACI (n=146) | Patients without ACI (n=205) | ||
| Gender, male | 228 (65.0) | 107 (73.3) | 121 (59.0) | 0.006 |
| Age, years | 62.5±9.6 | 61.2±9.2 | 63.5±9.8 | 0.047 |
| BMI, kg/m2 | 24.3±3.3 | 25.0±3.3 | 23.8±3.2 | 0.001 |
| Hypertension | 256 (72.9) | 114 (78.1) | 142 (69.3) | 0.067 |
| SBP, mmHg | 146.4±22.0 | 149.2±24.3 | 144.4±20.0 | 0.180 |
| DBP, mmHg | 87.3±13.6 | 90.0±15.6 | 85.3±11.6 | 0.020 |
| Hyperlipidemia | 191 (54.4) | 84 (57.5) | 107 (52.2) | 0.322 |
| HDL, mmol/L | 1.2±0.4 | 1.1±0.5 | 1.2±0.4 | 0.011 |
| LDL, mmol/L | 3.0±1.1 | 3.0±1.1 | 3.0±1.0 | 0.521 |
| TC, mmol/L | 4.8±1.2 | 4.6±1.3 | 4.9±1.2 | 0.053 |
| TG, mmol/L | 1.8±1.1 | 1.9±1.1 | 1.8±1.1 | 0.668 |
| Smoking | 159 (45.3) | 76 (52.1) | 83 (40.5) | 0.032 |
| Diabetes | 110 (31.3) | 61 (41.8) | 49 (23.9) | <0.001 |
| CHD | 54 (15.4) | 26 (17.8) | 28 (13.7) | 0.288 |
| Hypertensive agent | 214 (61.0) | 96 (65.8) | 118 (57.6) | 0.121 |
| Statin use | 135 (38.5) | 61 (41.8) | 74 (36.1) | 0.281 |
ACI, acute cerebral infarct; BMI, body mass index; CHD, coronary heart disease; DBP, diastolic blood pressure; HDL, high-density lipoprotein; LDL, low-density lipoprotein; SBP, systolic blood pressure; TC, total cholesterol; TG, triglycerides.